Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Click Me!

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. Aging Knowl. Environ., 3 November 2004
Vol. 2004, Issue 44, p. or19

OTHER RESOURCES

Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid {beta} Aggregation

Jason E. Gestwicki, Gerald R. Crabtree, and Isabella A. Graef

http://sageke.sciencemag.org/cgi/content/abstract/2004/44/or19

Abstract: Science 306, 865-869 (2004).

Protein aggregation is involved in the pathogenesis of neurodegenerative diseases and hence is considered an attractive target for therapeutic intervention. However, protein-protein interactions are exceedingly difficult to inhibit. Small molecules lack sufficient steric bulk to prevent interactions between large peptide surfaces. To yield potent inhibitors of {beta}-amyloid (A{beta}) aggregation, we synthesized small molecules that increase their steric bulk by binding to chaperones but also have a moiety available for interaction with A{beta}. This strategy yields potent inhibitors of A{beta} aggregation and could lead to therapeutics for Alzheimer's disease and other forms of neurodegeneration.

[Abstract/Full Text]

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products